Pharmaceuticals

Psychedelic Drugs Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the psychedelic drugs market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Psychedelic Drugs Market expected to grow between 2026 and 2030?

The psychedelic drugs market has seen significant expansion in recent years. It is forecast to increase from $6.33 billion in 2025 to $7.37 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.4%. This growth observed in past periods stems from factors such as the considerable unmet need in treating depression, early academic exploration of psychedelics, their use in underground and compassionate contexts, the limited effectiveness of standard antidepressants, and a rising recognition of mental health issues.

The psychedelic drugs market size is projected to experience swift expansion over the coming years, reaching $13.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. This anticipated growth is driven by factors such as regulatory approvals for medical applications, increased adoption by psychiatrists, a broadening indication pipeline, enhanced patient outcomes data, and strategic alliances between biotech firms and healthcare providers. Key developments foreseen in this period encompass the broadening of psychedelic-assisted therapy programs, a rise in clinical trials for mental health conditions, increasing acceptance of alternative psychiatric treatments, clearer regulatory guidelines for controlled substances, and greater investment from venture capital and pharmaceutical companies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

Which Drivers Are Influencing Market Acceleration In The Psychedelic Drugs Market?

A rise in mental illness cases is projected to drive the expansion of the psychedelic drugs market in the coming years. Mental illnesses are health conditions marked by changes in emotion, thinking, or behavior, including issues such as distress and post-traumatic stress disorder. Psychedelic drugs are employed for treating depression and post-traumatic stress disorder, with consistent use leading to a reduction in mental illnesses. For example, data from November 2023, sourced from the National Health Service, a UK-based government department, indicated that in 2023, around one in five individuals aged 8 to 25 years were estimated to experience a probable mental disorder. This breakdown showed that 20.3% of 8 to 16-year-olds, 23.3% of 17 to 19-year-olds, and 21.7% of 20 to 25-year-olds were affected. Consequently, the growing incidence of mental illnesses is fueling the expansion of the psychedelic drugs market.

What Leading Segments Are Studied In The Psychedelic Drugs Market?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Trends Are Driving The Growth Trajectory Of The Psychedelic Drugs Market?

Leading companies within the psychedelic drugs market are concentrating on developing innovative solutions, such as pharmaceutical-grade psilocybin formulations, to enhance therapeutic effectiveness, ensure safety, and expand treatment options for mental health disorders. A pharmaceutical-grade psilocybin formulation refers to psilocybin produced and standardized to meet pharmaceutical-grade quality, ensuring consistent purity, potency, and safety for medical use. For instance, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, introduced its natural psilocybin capsules in Australia for the treatment of TRD. Through this launch, Optimi Health aims to offer a clinically supported treatment option for patients, expand its footprint in the Australian mental health market, and accelerate the adoption of psychedelic-assisted therapies.

Which Key Market Players Are Investing In Expansion And Innovation Within The Psychedelic Drugs Market?

Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Regions Are Poised For Strategic Growth In The Psychedelic Drugs Market?

North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Psychedelic Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2026, By The Business Research Company

Psychedelic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Neurological Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795